ALKERMES | ALKS - 贸易债权人

股票价格

33.31

每天变化

-0.60 -1.77%

每月一次

13.42%

每年

19.65%

Q2 预测

32.32

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 5.49B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	贸易债权人	更改		日
AbbVie	USD 3.59B		28.65B	2025-12
Acadia Pharmaceuticals	USD 10.9M		10.84M	2025-12
ALKERMES	USD 107.95M		39.95M	2025-12
Amgen	USD 20.89B		1.25B	2025-12
Biogen	USD 432M		18.9M	2025-12
BioMarin Pharmaceutical	USD 759.03M		39.41M	2025-12
Bristol-Myers Squibb	USD 4.29B		1.14B	2025-09
Coherus Biosciences	USD 9.91M		14.98M	2025-12
Eli Lilly	USD 5.38B		1.12B	2025-12
Gilead Sciences	USD 715M		93M	2025-12
Heron Therapeutics	USD 8.99M		3.02M	2025-12
Ionis Pharmaceuticals	USD 14.33M		8.47M	2025-09
J&J	USD 10.46B		1.53B	2026-03
Malin Corporation	EUR 700K		200K	2024-12
Merck	USD 4.15B		102M	2025-09
Minerva Neurosciences	USD 640K		305K	2025-12
Nektar Therapeutics	USD 10.77M		4.79M	2025-12
Neurocrine Biosciences	USD 545.5M		425.6M	2025-12
Otsuka Holdings	JPY 225.56B		31.54B	2025-12
Ovoca Bio	EUR 186K		23K	2025-06
Pfizer	USD 5.02B		142M	2025-09
Regeneron Pharmaceuticals	USD 5.83B		4.93B	2025-12
Vertex Pharmaceuticals	USD 3.43B		600.9M	2025-12